Gulf Scientific Corporation Partners with Velsera to Pioneer Precision Medicine Platforms
Gulf Scientific Corporation (GSC), a leading provider of specialized laboratory solutions in the Gulf Cooperation Council (GCC), is thrilled to announce a strategic partnership with Velsera, a US-based leader in precision medicine platforms. This collaboration marks a significant expansion of GSC's Life Science Division, enabling GSC to represent Velsera in Saudi Arabia, Qatar, and Kuwait.
At the core of this partnership is the introduction of Velsera’s Clinical Genomics Workspace (CGW), a cutting-edge tool designed to optimize Next-Generation Sequencing (NGS) workflows. Additionally, the partnership will bring the Seven Bridges Platform, a secure, cloud-based system, to the region. This platform enhances the speed and efficiency of processing biomedical data, supporting a wide range of drug discovery activities.
By integrating these state-of-the-art technologies, GSC is positioned at the forefront of the life sciences industry in the GCC, advancing laboratory capabilities and fostering scientific innovation. The partnership with Velsera underscores GSC's commitment to enhancing its Life Science Division with the latest technologies and comprehensive services, ensuring its status as a leader in providing advanced laboratory solutions across the region.
